Mr Matthew Reilly > Kirkland & Ellis LLP > Washington DC, United States > Lawyer Profile

Kirkland & Ellis LLP
1301 Pennsylvania Avenue, N.W.
Washington, D.C., 20004
DISTRICT OF COLUMBIA
United States
Matthew Reilly photo

Position

Matt focuses on a wide range of antitrust matters, including complex transactions (and any related litigation), antitrust counseling, and government investigations. Matt is frequently relied upon to obtain regulatory clearance for many of the toughest, high profile deals. Representative clients and transactions include Bristol-Myers Squibb in its acquisition of Celgene, AbbVie in its pending acquisition of Allergan, Liqui-Box in its acquisition of DS Smith Plastics, Staples in its acquisition of Essendant, GlaxoSmithKline in its joint venture with Pfizer, Tronox in its acquisition of Cristal’s TiO2 business, Spectrum Brands’ sale of Rayovac to Energizer, Mazor Robotics’ sale to Medtronic, Sycamore Partners, Health Care Service Corporation, Blackstone, and Cinven.

Career

Former Assistant Director, Federal Trade Commission, Bureau of Competition, Mergers IV Division (2007-2012); Deputy Assistant Director, Mergers I Division (2004-2007). Awarded the Chairman’s Award (the FTC’s highest honor) for numerous successes in high-profile litigations.

Education

Georgetown University Law Center, J.D., 1995; Duke University, Sanford Institute of Public Policy, M.A., 1991; Colby College, B.A., 1988.

Lawyer Rankings

United States > Antitrust > Merger control

(Hall of Fame)

Matthew ReillyKirkland & Ellis LLP

Kirkland & Ellis LLP advises public and private companies, including major names such as Bain Capital, KKR, and Celanese on merger clearance for M&A and private equity transactions, combining a prolific record in HSR filings with strong capabilities across DOJ and FTC investigations, including Second Request proceedings, global approval processes, and antitrust litigation relating to mergers. The team has deep agency experience, with practice head Matthew Reilly, who is advising Celanese on its proposed $11 billion acquisition of Dupont’s Mobility & Materials business, having acted as assistant director of the FTC Mergers Division, and an expert in high-stakes merger trials across sectors such as pharma, telecoms, and defense. Andrea Murino, who held positions at the FTC and DOJ, focuses securing clearances from the agencies for major deals, including handling Second Requests. New York’s Ian John is a prolific advisor to major clients on complex cross-border transactions, while Marin Boney offers economics expertise and experience in analyzing joint ventures and vertical agreements alongside merger control capabilities. All lawyers are in Washington DC unless otherwise stated.